Author: James Dosman MD

Is the era of antibiotics coming to an end?

According to the World Health Organization, by 2022, more than 80% of existing antibiotics will become useless, as bacteria will become resistant to them. However, doctors do not give up. And they offer solutions that will allow creating new generations of drugs. Ri Yang and his colleagues from the University of Texas have adopted the […]

Consequences of Covid-19 in surviving patients

The long-term consequences of Covid-19 infection are the subject of intensive study around the world. In the January issue of the Lancet journal, the results of a cohort study on a population of 1,733 patients treated for covid infection in medical hospitals in Wuhan Province and discharged between January 7, 2020 and May 29, 2020 […]

Appendicitis in children and antibiotics

It is known that the main method of treatment of acute appendicitis is considered an emergency surgical removal of the organ. In uncomplicated forms of acute appendicitis, the operation is performed through an incision in the right lower abdomen or by laparoscopic method – through separate punctures of the abdominal wall. Scientists have found that […]

Recommendations for the use of antibiotic in respiratory infections

The American College of Physicians has issued guidelines for the recommendations for the use of antibiotic for common infections. The guidelines were published in the journal Annals of Internal Medicine. Often, doctors prescribe longer courses of antibiotic therapy to prevent the development of antibiotic resistance. However, experts noted that the excessive use of antimicrobial drugs […]

Antioxidants and hearing loss from antibiotics

So, antioxidants. Among the drugs of the class of antibiotics, there are practically no such drugs that do not have side effects and sometimes they are extremely dangerous. Scientists have found a way to combat one of the side effects of antibiotics – hearing loss. In the decades since the introduction of antibiotics in the […]

Vaccination in developing countries

Vaccination against pneumococcal infection in children in developing countries will not only reduce the incidence of pneumonia, meningitis and other dangerous diseases caused by Streptococcus pneumoniae, but also slow down the development of drug resistance of the bacterium. The use of a conjugate vaccine for the prevention of pneumococcal infections reduces the incidence of infection […]

Enzymes as a means of creating antibiotics

For example, builders know that precision and special tools are required to perform the task correctly. The same is true at the molecular level when creating antibiotics (combined and other, for example, amoxil). New data obtained at North Carolina State University demonstrates the possibility of using the enzyme as a “wrench” in the” assembly ” […]

A new approach in the development of antibiotics

Researchers from McMaster University in Canada have proposed a new approach to the development of antibiotics that may help solve the problem of drug resistance of infectious agents. The results of the study are published in the journal Nature Chemical Biology. The scientists drew attention to the fact that in contrast to laboratory conditions, where […]

Effectiveness of a new component of antibiotics

Scientists have announced, in their own words, a “major breakthrough” in the fight against antibiotic resistance, after a new component of antibiotics demonstrated effectiveness in the second phase of clinical trials. Resistance to antibiotic therapy is manifested in the insensitivity of the infection to certain antibacterial agents as a result of changes in microorganisms. Antibiotic-resistant […]

Immunity and antibiotics

There are strong links between the nature of nutrition, the development of the child and the state of his immunity. The scientific justification of these relations has been formulated in the last 15-20 years. However, if developing countries are characterized by the problem of protein and energy deficiency (actually starvation), then in countries with developed […]

Scroll to top